Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06284876
PHASE3

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Sponsor: Il-Yang Pharm. Co., Ltd.

View on ClinicalTrials.gov

Summary

To demonstrate the non-inferiority of Ilaprazole 10 mg to the active control in prevention of NSAIDs-associated peptic ulcer, as assessed by the proportion of subjects with peptic ulcer by Week 24

Official title: A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

416

Start Date

2024-07-23

Completion Date

2027-02-28

Last Updated

2025-05-30

Healthy Volunteers

No

Conditions

Interventions

DRUG

Ilaprazole

Ilaprazole 10 mg

DRUG

Lansoprazole

Lansoprazole 15 mg

DRUG

Ilaprazole Placebo

Placebo of Ilaprazole 10 mg

DRUG

Lansoprazole Placebo

Placebo of Lansoprazole 15 mg

Locations (2)

Chung Ang University Hospital

Seoul, South Korea

Chung-Ang University Hospital

Seoul, South Korea